About Diane Hayes, Ph.D

1 POSTS 0 COMMENTS

Diane Hayes, Ph.D is an epidemiologist, scientist, researcher, and writer who worked on large NCI/NIH sponsored clinical trials while in academia for 10 years. For nearly 20 years she directed clinically focused, evidence-based research and analysis for life science companies, health plans, insurers, hospitals, healthcare systems, ACOs, and government agencies. Hayes also co-founded a life science market insights firm, InCrowd (www.incrowdnow.com), and manages a large crowd of healthcare professionals who dialogue with industry leaders about products and services.

Fixing Our Flawed Drug Development Pipeline by Applying One Fundamental Tech...

Diane Hayes - November 20, 2018

Northeast Delta HSA partners with True Releaf CBD/Hemp Store to provide Drug Deactivation and Disposal Container November 28, 2023
Northeast Delta Human Services Authority (NEDHSA) unveiled a Deterra® Drug Deactivation and Disposal System Container on Tuesday, November 28, at True Releaf CBD/Hemp Store, located at 611 N. 4th Street, Monroe, La. 71201. This is the first partnership between a state agency and a...
Call Declined: New podcast follows the story of two artists, whose lives were transformed in prison after the systems meant to protect their wellbeing failed them November 28, 2023
Created by Lemonada Media and sponsored by the Sozosei Foundation, Call Declined follows the story of two talented artists, Kamisha Thomas and Aimee Wissman, whose lives were profoundly transformed in prison after the systems meant to protect and ensure their wellbeing failed them. Hosted...
Convergent Dental announces commercial availability of Solea® Protect™ to strengthen dental enamel using the Solea® All-Tissue Dental Laser November 28, 2023
Studies have shown that using Solea Protect in conjunction with fluoride is up to six times more effective at reducing mineral loss in tooth enamel than fluoride alone. WALTHAM, Mass., Nov. 28, 2023 /PRNewswire-PRWeb/ -- Tooth decay, also known as dental caries, can affect patients of all...

Diane Hayes

Fixing Our Flawed Drug Development Pipeline by Applying One Fundamental Tech...

LATEST NEWS

Preoperative Intravenous Iron Reduces the Need for Blood Transfusion in Colorectal Cancer Surgery

Are The Catholic Church and Its Hospitals A Marriage Made in Heaven?

Microbubbles: The Unlikely Key to Providing Accessible and Effective Cancer Treatments

Activating Bitter Taste Receptors May Kill Certain Cancer Cells

GRP78 – A Promising Target for CAR T-cells Helps Cancer Trick the Immune System

Preoperative Intravenous Iron Reduces the Need for Blood Transfusion in Colorectal Cancer Surgery

Are The Catholic Church and Its Hospitals A Marriage Made in Heaven?

Microbubbles: The Unlikely Key to Providing Accessible and Effective Cancer Treatments

Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?

Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...